Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,087 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Docetaxel Versus Androgen-Receptor Signaling Inhibitors (ARSI) as Second-Line Therapy After Failure of First-Line Alternative ARSI for the Elderly ≥ 75 Years Old With Metastatic Castration-Resistant Prostate Cancer (mCRPC): A SPARTACUSS-Meet-URO 26 Real-World Study.
Patrikidou A, Saieva C, Lee-Ying R, Nuzzo PV, Zarif TE, McClure H, Davidsohn M, Eid M, Spinelli GP, Catalano F, Cremante M, Fotia G, Rossetti S, Valenca L, Vauchier C, Ottanelli C, Andrade L, Gennusa V, Mestre RP, Fornarini G, Pignata S, Procopio G, Santini D, Ravi P, Sweeney C, Heng D, De Giorgi U, Fizazi K, Russo A, Francini E; SPARTACUSS Group. Patrikidou A, et al. Among authors: andrade l. Clin Genitourin Cancer. 2024 Oct 5;22(6):102230. doi: 10.1016/j.clgc.2024.102230. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 39461026 Free article.
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer.
Chi KN, Rathkopf D, Smith MR, Efstathiou E, Attard G, Olmos D, Lee JY, Small EJ, Pereira de Santana Gomes AJ, Roubaud G, Saad M, Zurawski B, Sakalo V, Mason GE, Francis P, Wang G, Wu D, Diorio B, Lopez-Gitlitz A, Sandhu S; MAGNITUDE Principal Investigators. Chi KN, et al. J Clin Oncol. 2023 Jun 20;41(18):3339-3351. doi: 10.1200/JCO.22.01649. Epub 2023 Mar 23. J Clin Oncol. 2023. PMID: 36952634 Free PMC article. Clinical Trial.
Effect of crossover from placebo to darolutamide on overall survival in men with non-metastatic prostate cancer: sensitivity analyses from the randomised phase 3 ARAMIS study.
Shore ND, Fizazi K, Tammela TLJ, Luz M, Salas MP, Ouellette P Jr, Lago S, Bastos DA, Jansz GK, Cárcano FM, Andrade L, Pliskin M, Lazaretti N, Arruda L, Correa Ochoa JJ, Kuss I, Kappeler C, Sarapohja T, Smith M. Shore ND, et al. Among authors: andrade l. Eur J Cancer. 2023 Sep 17;195:113342. doi: 10.1016/j.ejca.2023.113342. Online ahead of print. Eur J Cancer. 2023. PMID: 39491396 Free article.
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Kappeler C, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2019 Mar 28;380(13):1235-1246. doi: 10.1056/NEJMoa1815671. Epub 2019 Feb 14. N Engl J Med. 2019. PMID: 30763142 Clinical Trial.
Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Le Berre MA, Petrenciuc O, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2020 Sep 10;383(11):1040-1049. doi: 10.1056/NEJMoa2001342. N Engl J Med. 2020. PMID: 32905676 Clinical Trial.
Consensus on diagnosis and management of non-metastatic castration resistant prostate cancer in Brazil: focus on patient, selection, treatment efficacy, side effects and physician's perception according to patient comorbidities.
Maluf F, Soares A, Avanço G, Hada AL, Cardoso APG, Carneiro A, Herchenhorn D, Jardim DLF, Schutz FA, Kater FR, Pereira FMT, Monteiro FSM, Morbeck IAP, Reolon JFN, da Trindade KM, Andrade LMQDS, Nogueira LM, Furoni R, Natel RA, Dos Reis RB, Fogace RN, Souza VC. Maluf F, et al. Int Braz J Urol. 2021 Mar-Apr;47(2):359-373. doi: 10.1590/S1677-5538.IBJU.2020.0249. Int Braz J Urol. 2021. PMID: 33284538 Free PMC article.
Frequency of anti-MOG antibodies in serum and CSF of patients with possible autoimmune encephalitis: Results from a Brazilian multicentric study.
de Freitas Dias B, Toso FF, Barreto MESF, Dellavance A, Thomaz RB, Kowacs PA, Teive H, Spitz M, Juliano AFB, Rocha LJA, Granja VNT, Braga-Neto P, Nóbrega PR, Oliveira-Filho J, Dias RM, Amoras JAP, Pereira RBR, Júnior COG, Maia FM, Santos ML, de Melo ES, Júnior AWDN, Lin K, Paolilo RB, Krueger MB, Barsottini OGP, Endmayr V, Andrade LEC, Hoftberger R, Dutra LA. de Freitas Dias B, et al. Among authors: andrade lec. Mult Scler Relat Disord. 2024 Nov 14;92:106171. doi: 10.1016/j.msard.2024.106171. Online ahead of print. Mult Scler Relat Disord. 2024. PMID: 39579646
Two case reports of the parasitism of Ophionyssus natricis (Gervais, 1844) (Mesostigmata: Macronyssidae) in captive Epicrates crassus (Cope) (Squamata: Boidae) in Brazil.
Mello-Oliveira VS, Jacinavicius FC, Andrade LO, Siconelli MJL, Pereira FMAM, Soares-Neto LL, Hippólito AG, Hoppe EGL, Dowling APG, Barros-Battesti DM, Bassini-Silva R. Mello-Oliveira VS, et al. Among authors: andrade lo. Syst Parasitol. 2024 Nov 21;102(1):7. doi: 10.1007/s11230-024-10206-8. Syst Parasitol. 2024. PMID: 39570477
2,087 results